Search
for
Sort by
Research 31–60 of 168
- Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes
- Mechanisms of Puerariae Lobatae Radix in regulating sebaceous gland secretion: insights from network pharmacology and experimental validation
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Ursolic acid, a pentacyclic triterpene from Ochrosia elliptica Labill leaves and its role in the management of polycystic ovary syndrome (PCOS)
- Intracrine androgen biosynthesis, metabolism and action revisited
- A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome
- Synthesis and Actions of 5α-Reduced Metabolites of Testosterone in the Nervous System
- Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®)
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- 17α-Acetoxy-6-bromo-16β-methylpregna-4,6-diene-3,20-dione
- Glucocorticoids and mineralocorticoids in hair: facilitating accurate diagnosis of adrenal-related endocrine disorders
- Alternative androgen pathways
- Exploring the Inhibitory Potential of Phytosterols β-Sitosterol, Stigmasterol, and Campesterol on 5-Alpha Reductase Activity in the Human Prostate: An In Vitro and In Silico Approach
- Chapter 23. Therapeutic Control of Androgen Action
- Dermatological Drugs, Topical Agents, and Cosmetics
- Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome
- Effects of halogenated analogues of cortisol and progesterone upon hair growth in castrated mice.
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Factors Driving Unique Urination Phenotypes of Male and Female 9-week-old C57BL/6J Mice
- Epitestosterone
- Hyperandrogenism in Adolescent Girls
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Oxidative Activity of the Type 2 Isozyme of 17β-Hydroxysteroid Dehydrogenase (17β-HSD) Predominates in Human Sebaceous Glands
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- The Role of Cytochrome P-450 in Dermatology
- Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men
- Crystal Structure of 3-Oxo-4-Aza-5-Alpha-Androstone-17 β-Tert-Butyl Carboxamide with an O···H–(C, N) Acceptor Four-Center Hydrogen Bond
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- 5-Alpha-reductase deficiency in a Saudi "girl"
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency